GLUE

Monte Rosa Therapeutics, Inc.$18.23+0.84 (+4.91%)

Prev Close$17.10·MCap$1.19B·P/E—·Vol816.6K·Yield—

▲

Buys (12M)

$0.00

▼

Sells (12M)

$1.97M

◆

Net Activity

Net Seller

$1.97M

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Monte Rosa Therapeutics, Inc. (GLUE) has been exclusively selling, with 0 insider purchases totaling $0.00 and 18 insider sales totaling $1.97M. The most recent insider transaction was by Warmuth Markus (director, officer: President & CEO), who sold $106.3K worth of shares on Jun 2, 2026. Monte Rosa Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.19B.

GLUE Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jun 2, 2026	Warmuth Markus	director, officer: President & CEO	Sell	5,466	$19.44	$106.3K	595,006
Jun 1, 2026	Townson Sharon	officer: Chief Scientific Officer	Sell	6,000	$19.87	$119.2K	67,845
May 28, 2026	Champoux Jennifer	officer: Chief Operating Officer	Sell	2,175	$20.00	$43.5K	62,371
May 26, 2026	Champoux Jennifer	officer: Chief Operating Officer	Sell	2,176	$19.00	$41.3K	62,371
May 22, 2026	Manning Anthony M.	director	Sell	10,000	$18.01	$180.1K	0Exit
May 5, 2026	Warmuth Markus	director, officer: President & CEO	Sell	5,467	$18.92	$103.4K	600,004
Apr 15, 2026	Warmuth Markus	director, officer: President & CEO	Sell	8,000	$17.64	$141.1K	605,471
Apr 10, 2026	Nickson Philip	officer: Chief Business & Legal Officer	Sell	5,845	$17.69	$103.4K	55,000
Mar 5, 2026	Dunn Edmund	officer: Principal Accounting Officer	Sell	139	$17.96	$2.5K	22,554
Mar 2, 2026	Dunn Edmund	officer: Principal Accounting Officer	Sell	25,700	$18.09	$464.9K	22,693-53%
Feb 24, 2026	Janku Filip	officer: Chief Medical Officer	Sell	9,189	$19.50	$179.2K	65,837
Jan 9, 2026	Warmuth Markus	director, officer: President & CEO	Sell	5,466	$23.49	$128.4K	620,696
Jan 5, 2026	Champoux Jennifer	officer: Chief Operating Officer	Sell	2,629	$15.17	$39.9K	62,371
Jan 5, 2026	Dunn Edmund	Principal Accounting Officer	Sell	1,039	$15.17	$15.8K	0
Jan 5, 2026	Janku Filip	officer: Chief Medical Officer	Sell	3,155	$15.17	$47.9K	75,026
Jan 5, 2026	Townson Sharon	officer: Chief Scientific Officer	Sell	3,155	$15.17	$47.9K	67,845
Jan 5, 2026	Warmuth Markus	director, officer: President & CEO	Sell	10,135	$15.17	$153.7K	624,403
Jan 2, 2026	Nickson Philip	Chief Business & Legal Officer	Sell	3,155	$15.17	$47.9K	0
Mar 24, 2025	Leo Chandra P.	Director	Buy	10,000	$5.84	$58.4K	0
Oct 30, 2024	Versant Venture Capital VI, L.P.		Sell	157,895	$9.44	$1.49M	2,007,948
Sep 24, 2024	Versant Venture Capital VI, L.P.		Sell	1,132,566	$6.53	$7.40M1.7% OS	5,099,336
Sep 13, 2024	Versant Venture Capital VI, L.P.		Sell	567,213	$6.00	$3.40M0.9% OS	6,257,218
Jul 9, 2024	Dunn Edmund	Principal Accounting Officer	Sell	1,610	$3.83	$6.2K	13,944
Jun 5, 2024	Dunn Edmund	Principal Accounting Officer	Sell	1,207	$4.04	$4.9K	15,554
Jun 30, 2021	Bolzon Bradley J PhD	Director	Buy	157,895	$19.00	$3.00M	2,097,938
Jun 30, 2021	Cormorant Asset Management, LP		Buy	600,000	$19.00	$11.40M0.9% OS	3,202,200
Jun 30, 2021	Yang Rick	10% Owner	Buy	1,050,000	$19.00	$19.95M1.6% OS	7,692,298

GLUE Insider Buying Activity

The following table shows recent insider purchases of Monte Rosa Therapeutics, Inc. (GLUE) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 24, 2025	Leo Chandra P.	Director	Buy	10,000	$5.84	$58.4K	0
Jun 30, 2021	Bolzon Bradley J PhD	Director	Buy	157,895	$19.00	$3.00M	2,097,938
Jun 30, 2021	Cormorant Asset Management, LP		Buy	600,000	$19.00	$11.40M0.9% OS	3,202,200
Jun 30, 2021	Yang Rick	10% Owner	Buy	1,050,000	$19.00	$19.95M1.6% OS	7,692,298

GLUE Insider Selling Activity

The following table shows recent insider sales of Monte Rosa Therapeutics, Inc. (GLUE) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jun 2, 2026	Warmuth Markus	director, officer: President & CEO	Sell	5,466	$19.44	$106.3K	595,006
Jun 1, 2026	Townson Sharon	officer: Chief Scientific Officer	Sell	6,000	$19.87	$119.2K	67,845
May 28, 2026	Champoux Jennifer	officer: Chief Operating Officer	Sell	2,175	$20.00	$43.5K	62,371
May 26, 2026	Champoux Jennifer	officer: Chief Operating Officer	Sell	2,176	$19.00	$41.3K	62,371
May 22, 2026	Manning Anthony M.	director	Sell	10,000	$18.01	$180.1K	0Exit
May 5, 2026	Warmuth Markus	director, officer: President & CEO	Sell	5,467	$18.92	$103.4K	600,004
Apr 15, 2026	Warmuth Markus	director, officer: President & CEO	Sell	8,000	$17.64	$141.1K	605,471
Apr 10, 2026	Nickson Philip	officer: Chief Business & Legal Officer	Sell	5,845	$17.69	$103.4K	55,000
Mar 5, 2026	Dunn Edmund	officer: Principal Accounting Officer	Sell	139	$17.96	$2.5K	22,554
Mar 2, 2026	Dunn Edmund	officer: Principal Accounting Officer	Sell	25,700	$18.09	$464.9K	22,693-53%
Feb 24, 2026	Janku Filip	officer: Chief Medical Officer	Sell	9,189	$19.50	$179.2K	65,837
Jan 9, 2026	Warmuth Markus	director, officer: President & CEO	Sell	5,466	$23.49	$128.4K	620,696
Jan 5, 2026	Champoux Jennifer	officer: Chief Operating Officer	Sell	2,629	$15.17	$39.9K	62,371
Jan 5, 2026	Dunn Edmund	Principal Accounting Officer	Sell	1,039	$15.17	$15.8K	0
Jan 5, 2026	Janku Filip	officer: Chief Medical Officer	Sell	3,155	$15.17	$47.9K	75,026
Jan 5, 2026	Townson Sharon	officer: Chief Scientific Officer	Sell	3,155	$15.17	$47.9K	67,845
Jan 5, 2026	Warmuth Markus	director, officer: President & CEO	Sell	10,135	$15.17	$153.7K	624,403
Jan 2, 2026	Nickson Philip	Chief Business & Legal Officer	Sell	3,155	$15.17	$47.9K	0
Oct 30, 2024	Versant Venture Capital VI, L.P.		Sell	157,895	$9.44	$1.49M	2,007,948
Sep 24, 2024	Versant Venture Capital VI, L.P.		Sell	1,132,566	$6.53	$7.40M1.7% OS	5,099,336
Sep 13, 2024	Versant Venture Capital VI, L.P.		Sell	567,213	$6.00	$3.40M0.9% OS	6,257,218
Jul 9, 2024	Dunn Edmund	Principal Accounting Officer	Sell	1,610	$3.83	$6.2K	13,944
Jun 5, 2024	Dunn Edmund	Principal Accounting Officer	Sell	1,207	$4.04	$4.9K	15,554